- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Plasma Homocysteine in New Zealand
Total 881 results
-
PfizerCompletedMultiple MyelomaUnited States, Germany, Czech Republic
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted
-
Marcelo Pasquini, MDNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsActive, not recruiting
-
OncotherapeuticsCelgene CorporationTerminatedMultiple MyelomaUnited States
-
SCRI Development Innovations, LLCNovartis; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
Fortis Therapeutics, Inc.CompletedMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed RemissionUnited States
-
AbbVieTerminatedMultiple MyelomaUnited States, France, Germany, Spain
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
Hoffmann-La RocheRecruitingMultiple MyelomaUnited States, Italy, Spain, Australia, Belgium, Israel, Germany, France
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); National Marrow Donor Program; Blood and Marrow...CompletedMultiple MyelomaUnited States
-
AmgenCompletedMultiple MyelomaUnited States
-
PfizerActive, not recruitingMultiple MyelomaUnited States, Canada, Spain, Belgium, United Kingdom, Australia, Japan, France, Germany, Poland
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
TeneoOne Inc.RecruitingMultiple MyelomaIsrael, United States, Canada, Spain, France, Denmark, United Kingdom
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of RochesterTerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma | Graft Versus Host Disease | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Poseida Therapeutics, Inc.California Institute for Regenerative Medicine (CIRM)TerminatedMultiple MyelomaUnited States
-
Oncopeptides ABPrecision For MedicineCompletedMultiple MyelomaSpain, United States, France, Italy
-
Janssen Research & Development, LLCApproved for marketingMultiple MyelomaUnited States, United Kingdom, Spain, Brazil, Russian Federation, Japan
-
NovartisCompletedMultiple MyelomaCanada, United States, Australia, Taiwan, Ireland
-
AbbVieJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, Denmark, France, Germany, Japan
-
ASH Research CollaborativeModernaTX, Inc.Enrolling by invitation
-
AmgenCompletedMultiple MyelomaUnited States, Canada
-
AmgenTerminated
-
Janssen Research & Development, LLCCompleted
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, France, Spain, Germany, Greece
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
Accelerated Community Oncology Research NetworkMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Japan
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Spain
-
Prothena Biosciences Ltd.CompletedAL AmyloidosisUnited States, Spain, Australia, Germany, United Kingdom, France, Greece, Israel, Italy, Austria
-
CephalonTerminated
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Hoffmann-La RocheCompleted
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain
-
CelgeneActive, not recruitingMultiple MyelomaFrance, United States, Canada, Spain, Italy
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
Gilead SciencesCompletedLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Low-Grade | Lymphoma, Small Lymphocytic | Leukemia, Prolymphocytic | NHL | CLL | Leukemia, Lymphocytic, Chronic | Lymphoma, Intermediate-Grade | Lymphoma, Large-Cell | Lymphoma, Mixed-Cell | Lymphoma, Small-Cell | Leukemia, B-Cell, Chronic | Leukemia... and other conditionsUnited States
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationAmyloidosis, Immunoglobulin Light-chainUnited States, Canada
-
Poseida Therapeutics, Inc.Roche-GenentechRecruitingMultiple MyelomaUnited States
-
Pharmacyclics LLC.CompletedMultiple MyelomaUnited States, Canada
-
Pharmacyclics LLC.Celgene CorporationTerminatedMultiple MyelomaUnited States, Spain, Australia, Czechia, Germany, Greece
-
Millennium Pharmaceuticals, Inc.Completed
-
Multiple Myeloma Research FoundationSpectrum Health Hospitals; Translational Genomics Research Institute; Van Andel...CompletedMultiple MyelomaUnited States, Spain, Canada
-
Janssen Research & Development, LLCActive, not recruiting
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Netherlands, Spain, France, Sweden
-
Genentech, Inc.RecruitingMultiple MyelomaUnited States, Canada, Spain, Australia
-
Janssen Research & Development, LLCCompleted